Administrative Core
行政核心
基本信息
- 批准号:10663222
- 负责人:
- 金额:$ 38.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AchievementAction ResearchAdvisory CommitteesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnimal WelfareAreaAwardBlood VesselsClinicalClinical SciencesCollaborationsCommunitiesConsultationsCreativenessDataDementiaDevelopmentEducationEnsureEthicsFeedbackFosteringGoalsGrowthInfrastructureInstitutionInterdisciplinary EducationInterdisciplinary StudyLeadLeadershipMetabolicMissionNatureParticipantPerformancePhenotypePoliciesProcessProgram EvaluationRegulationResearchResearch PersonnelResourcesRiskRoleSeriesServicesSpecimenTranslational ResearchUniversitiesVisionWorkcareerdata managementdisease heterogeneityforesthealth disparityhuman subjectimaging biomarkerinnovationmembermodel designneuropathologynormal agingnovelprogramsrepositorysuccesstranslational modeltranslational scientisttrial designvascular factor
项目摘要
Administrative Core – Project Summary
The Wake Forest Alzheimer’s Disease Research Center (WF ADRC) provides a comprehensive, integrated
infrastructure to facilitate research aimed at identifying the causes of AD, and elucidating the role of
vascular/metabolic factors in transitions from normal aging to AD and other dementias. The WF ADRC also
provides resources to better understand disease heterogeneity and the multi-faceted impact of health
disparities on AD risk. The Administrative Core ensures that ADRC scientific and programmatic goals are
achieved by providing visionary oversight and effective governance to all Center activities, and scientific
direction to the Center as a whole. The Core will be directed by an Executive Committee, whose members
include the Director, Associate Directors, Core and Service Leaders, and the Program Manager. The
Executive Committee will be guided by an Internal Advisory Committee (IAC) composed of institutional
leaders who meet regularly to facilitate the achievement of ADRC aims and promote the growth of AD
research at WF. The Core will be also guided by an External Advisory Committee (EAC), chosen in
consultation with the NIA and consisting of members of other ADRCs and scientific leaders. The EAC will
meet annually to review WF ADRC program goals and progress. We will also seek input about ADRC
engagement with our community and participants through our Community and Participant Advisory Boards.
Expansion of AD-related research and impactful utilization of valuable scientific resources are important
goals for all ADRCs. The Administrative Core Committee for Resource Utilization and Research EXpansion
(CRUX) oversees a coordinated series of activities to ensure that ADRC resources contribute to high-impact
research and that new translational scientists are brought into the field. In the past cycle, the CRUX facilitated
the rapid and successful integration of our new ADRC into the larger ADRC network, providing data and
biospecimen resources to the National Alzheimer’s Coordinating Center (NACC), the National Centralized
Repository for AD (NCRAD), other ADRCs and AD investigators world-wide. Through its distinctive theme and
innovative phenotyping, our ADRC contributes to National Alzheimer’s Project Act (NAPA) Research
Milestones involving metabolic/vascular factors, health disparities, translational models and trial design.
WF ADRC’s ability to achieve its scientific and educational mission depends on the efficacy of its
Administrative Core. In its inaugural cycle, Core leaders developed and led vigorous interdisciplinary research
and educational programs. We have established effective Executive and Internal Advisory Committees,
launched a successful pilot program that has drawn creative new investigators to AD research, and established
multiple high-impact collaborations. Our comprehensive activities to date demonstrate that Administrative Core
members have the vision, influence, and commitment to ensure the far-reaching success of the WF ADRC.
行政核心 - 项目摘要
维克森林阿尔茨海默氏病研究中心(WF ADRC)提供了全面的,整合的
基础设施促进旨在确定AD原因的研究,并阐明
从正常衰老到AD和其他痴呆症的过渡中的血管/代谢因子。 WF ADRC也
提供资源以更好地理解疾病异质性和健康的多方面影响
广告风险的差异。行政核心确保ADRC科学和程序化目标是
通过为所有中心活动提供有远见的监督和有效的治理来实现
整体中心的方向。核心将由执行委员会指导,其成员
包括董事,副董事,核心和服务负责人以及计划经理。
执行委员会将由内部咨询委员会(IAC)指导,该委员会由机构组成
定期开会以促进ADRC目标并促进广告发展的领导者
WF的研究。核心还将受到外部咨询委员会(EAC)的指导
与NIA协商,由其他ADRC和科学领导者的成员组成。 EAC会
每年开会以审查WF ADRC计划目标和进度。我们还将寻求有关ADRC的意见
通过我们的社区和参与者咨询委员会与我们的社区和参与者互动。
扩展与广告相关的研究和有影响力的有价值科学资源的利用很重要
所有ADRC的目标。资源利用与研究扩展的行政核心委员会
(CRUX)监督一系列协调的活动,以确保ADRC资源有助于高影响力
研究和新翻译的科学家被带入该领域。在过去的周期中,症结已准备就绪
我们的新ADRC快速而成功地集成到较大的ADRC网络中,提供数据和
国家阿尔茨海默氏症协调中心(NACC),国家集中式的生物循环资源
全球其他ADRC和AD调查人员的AD存储库(NCRAD)。通过其独特的主题和
创新的表型,我们的ADRC为国家阿尔茨海默氏症的项目法(NAPA)研究做出了贡献
涉及代谢/血管因素,健康差异,翻译模型和试验设计的里程碑。
WF ADRC实现其科学和教育使命的能力取决于其效率
行政核心。在首届周期中,核心领导者发展并领导了有力的跨学科研究
和教育计划。我们已经成立了有效的执行和内部咨询委员会,
启动了一项成功的试点计划,该计划吸引了创造性的新调查人员进行广告研究,并建立了
多次高影响合作。迄今为止,我们的全面活动证明了行政核心
成员具有确保WF ADRC取得深远的成功的愿景,影响力和承诺。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUZANNE CRAFT其他文献
SUZANNE CRAFT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUZANNE CRAFT', 18)}}的其他基金
PET imaging of microtubules in cognitively normal and impaired older adults
认知正常和受损老年人的微管 PET 成像
- 批准号:
10915761 - 财政年份:2023
- 资助金额:
$ 38.68万 - 项目类别:
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
开发早期阿尔茨海默病样神经病理学和症状学的创新黑长尾猴(Chlorocebus aethiops sabaeus)模型
- 批准号:
10483200 - 财政年份:2021
- 资助金额:
$ 38.68万 - 项目类别:
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
开发早期阿尔茨海默病样神经病理学和症状学的创新黑长尾猴(Chlorocebus aethiops sabaeus)模型
- 批准号:
10281758 - 财政年份:2021
- 资助金额:
$ 38.68万 - 项目类别:
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
开发早期阿尔茨海默病样神经病理学和症状学的创新黑长尾猴(Chlorocebus aethiops sabaeus)模型
- 批准号:
10663993 - 财政年份:2021
- 资助金额:
$ 38.68万 - 项目类别:
Development of an Innovative Vervet (Chlorocebus aethiops sabaeous) Model of Early Alzheimer’s-like Neuropathology and Symptomatology
开发早期阿尔茨海默病样神经病理学和症状学的创新黑长尾猴(Chlorocebus aethiops sabaeous)模型
- 批准号:
10845821 - 财政年份:2021
- 资助金额:
$ 38.68万 - 项目类别:
相似国自然基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚热带高密度城市居民的步行动态热舒适需求的影响因素与量化体系研究
- 批准号:52308121
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
- 批准号:82371140
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
成骨谱系功能异常在X-连锁显性低血磷性佝偻病/骨软化症发病中的作用与机制研究
- 批准号:82370888
- 批准年份:2023
- 资助金额:65.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
相似海外基金
Linking rare primate ganglion cells to downstream visual functions
将稀有灵长类神经节细胞与下游视觉功能联系起来
- 批准号:
10721221 - 财政年份:2023
- 资助金额:
$ 38.68万 - 项目类别:
Deep learning to enable the genetic analysis of aorta
深度学习可实现主动脉的遗传分析
- 批准号:
10807379 - 财政年份:2023
- 资助金额:
$ 38.68万 - 项目类别:
NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION
先天性巨细胞病毒 (CCMV) 感染的新生儿筛查随访研究
- 批准号:
10937099 - 财政年份:2023
- 资助金额:
$ 38.68万 - 项目类别: